MHRA kwadoro Epidyolex (cannabidiol) maka ịgwọ ọrịa akwara sclerosis

site Ndị otu Inc.

2021-08-17-MHRA kwadoro Epidyolex (cannabidiol) maka ọgwụgwọ tuberous sclerosis complex.

GW Pharmaceuticals enwetala nkwado maka Epidyolex®(cannabidiol) maka ọgwụgwọ ọgụ metụtara tuberous sclerosis complex (TSC) na UK.

GW Pharmaceuticals, ugbu a akụkụ nke Jazz Pharmaceuticals, ekwuputala na UK Medicine and Healthcare Product Regulatory Agency (MHRA) kwadoro ihe ngosi ọhụrụ maka Epidyolex® (cannabidiol); dị ka ọgwụgwọ mgbakwunye nke mgbagwoju anya nke jikọtara ya na tuberous sclerosis complex (TSC) maka ndị ọrịa dị afọ abụọ na karịa. Ọkpụkpụ Sclerosis Tuberous (TSC) bụ ọnọdụ eketa nke etuto ahụ na-adịghị mma na-etolite n'ebe dị iche iche n'ime ahụ.

Cannabidiol maka ọgwụgwọ nke etuto ahụ na akwụkwụ

"Anyị na-anabata mkpebi MHRA maka ihe ngosi ọhụrụ a, nke na-anọchite anya nzọụkwụ dị mkpa maka ndị ọrịa TSC na UK," Chris Tovey, onye isi oche onye isi oche na Jazz Pharmaceuticals kwuru.
Epidyolex, ọgwụ izizi sitere na cannabis, ka ndị US Food and Drug Administration (FDA) kwadoro maka ojiji na US yana European Commission (EC) maka iji ya na European Union (EU). Ọ bụ ngwọta ọnụ nwere cannabidiol dị ọcha nke ukwuu (CBD). Ụlọ Ọrụ Na-ahụ Maka Ọgwụ na Europe (EMA) akwadoro ọgwụ ahụ maka ọgwụgwọ ọdịdọ metụtara LGS, Dravet syndrome na TSC.

Gụkwuo na europeanpharmaceuticalreview.com (Isi, EN)

Ihe ndị metụtara ya

Hapụ ikwu

[ọkọlọtọ adrate = "89"]